|
|
41
|
|
|
4181W
|
|
|
OCREVUS 300MG INJ (ROC) OCRELIZUMAB (BQ)
|
|
|
OCRELIZUMAB
|
|
|
OCREVUS
|
|
|
10ML
|
|
|
BQ
|
|
|
17533.19
|
|
|
17533.189
|
|
|
300MG
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
ROC
|
|
|
ROCHE SERVICIOS S.A.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
9220
|
|
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|